{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:39Z","timestamp":1787010039428,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Pneumonia is a leading cause of antibiotic use for children. This study aimed to assess nationwide antibiotic prescribing patterns for pediatric pneumonia in South Korea between 2016 and 2023, a period encompassing both epidemic and nonepidemic periods of\n                      <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic>\n                      pneumonia (MPP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using national claims data from the Health Insurance Review and Assessment Service, we analyzed antibiotic prescriptions for patients under 18 years diagnosed with bacterial pneumonia (International Classification of Diseases, 10th Revision codes; viral pneumonia was excluded). Antibiotic use was measured in days of therapy per 1000 patient-days (inpatients) or per 1000 patients (outpatients).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 8.7 million inpatient days and 3.5 million outpatient visits, the 2\u20134 years group accounted for the highest burden (497.1 inpatient days and 161.6 outpatient visits per 1000 population). Macrolides were the most prescribed class in both inpatients [805.1 days of therapy (DOT)\/1000 patient-days] and outpatients (4898.0 DOT\/1000 patients), except in infants, where third-generation cephalosporins predominated. Use of third-generation cephalosporins increased sharply from 2022 and became the most prescribed class in 2023. Tertiary hospitals had higher use of tetracyclines (26.8 DOT\/1000 patient-days) and quinolones but lower use of beta-lactams than other facility types. Antibiotic prescribing peaked in the fourth quarter of each year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Among children in South Korea diagnosed with bacterial pneumonia, macrolides were most frequently prescribed, and prescriptions for third-generation cephalosporins showed an increasing trend. These findings underscore challenges in antimicrobial stewardship and need for strengthened nationwide antimicrobial stewardship policies for pediatric pneumonia tailored to age, setting, and seasonal trends.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004995","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:02:18Z","timestamp":1758232938000},"page":"152-158","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Trends in Antibiotic Use for Pediatric Patients With Pneumonia: A Nationwide Analysis in South Korea (2016\u20132023)"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6777-0494","authenticated-orcid":false,"given":"Ji Young","family":"Park","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Korea University Ansan Hospital, Ansan, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2634-1738","authenticated-orcid":false,"given":"Jungmi","family":"Chae","sequence":"additional","affiliation":[{"name":"Department of Research, Health Insurance Review & Assessment Service (HIRA), Wonju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-0715","authenticated-orcid":false,"given":"Young June","family":"Choe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-7289","authenticated-orcid":false,"given":"Yujeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Research, Health Insurance Review & Assessment Service (HIRA), Wonju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8157-8618","authenticated-orcid":false,"given":"Jihye","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Research, Health Insurance Review & Assessment Service (HIRA), Wonju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-1807","authenticated-orcid":false,"given":"Dong-Sook","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Health Administration, College of Health, Kongju National University, Gongju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0107-0724","authenticated-orcid":false,"given":"Hyunju","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"1287051","DOI":"10.3389\/fcimb.2023.1287051","article-title":"Editorial: antimicrobial resistance in pediatric infectious diseases: antimicrobial resistance, resistance mechanisms and antimicrobial use.","volume":"13","author":"Yu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015.","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jpeds.2016.11.027","article-title":"Antibiotic use in children - a cross-national analysis of 6 countries.","volume":"182","author":"Youngster","year":"2017","journal-title":"J Pediatr"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2024.02.003","article-title":"WHO\u2019s essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections.","volume":"30","author":"Moja","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(18)30547-4","article-title":"Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.","volume":"19","author":"Hsia","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41479-017-0031-4","article-title":"Encouraging rational antibiotic use in childhood pneumonia: a focus on Vietnam and the Western Pacific Region.","volume":"9","author":"Phuong","year":"2017","journal-title":"Pneumonia (Nathan)"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"1095166","DOI":"10.3389\/fped.2023.1095166","article-title":"The dilemma of improving rational antibiotic use in pediatric community-acquired pneumonia.","volume":"11","author":"Nguyen","year":"2023","journal-title":"Front Pediatr"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children.","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jinf.2008.02.018","article-title":"Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period.","volume":"56","author":"Eun","year":"2008","journal-title":"J Infect"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3201\/eid2607.200017","article-title":"Macrolide-resistant Mycoplasma pneumoniae infections in pediatric community-acquired pneumonia.","volume":"26","author":"Chen","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3390\/antibiotics12111623","article-title":"Characteristics of the Mycoplasma pneumoniae epidemic from 2019 to 2020 in Korea: macrolide resistance and co-infection trends.","volume":"12","author":"Shin","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.3346\/jkms.2023.38.e127","article-title":"Twenty-five year trend change in the etiology of pediatric invasive bacterial infections in Korea, 1996-2020.","volume":"38","author":"Song","year":"2023","journal-title":"J Korean Med Sci"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.3346\/jkms.2023.38.e339","article-title":"Etiology and clinical characteristics of community-acquired pneumonia in Korean children during the pre-COVID-19 period, 2015-2020.","volume":"38","author":"Suh","year":"2023","journal-title":"J Korean Med Sci"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3201\/eid1908.121455","article-title":"Macrolide resistance of mycoplasma pneumoniae, South Korea, 2000-2011.","volume":"19","author":"Hong","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12879-017-2500-z","article-title":"Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.","volume":"17","author":"Yoon","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3390\/microorganisms12091806","article-title":"Clinical manifestations, macrolide resistance, and treatment utilization trends of Mycoplasma pneumoniae pneumonia in children and adolescents in South Korea.","volume":"12","author":"Lee","year":"2024","journal-title":"Microorganisms"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/jac\/dkaa194","article-title":"COVID-19 and the potential long-term impact on antimicrobial resistance.","volume":"75","author":"Rawson","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/heapol\/czn037","article-title":"Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage.","volume":"24","author":"Kwon","year":"2009","journal-title":"Health Policy Plan"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/S1473-3099(16)30386-3","article-title":"A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail.","volume":"17","author":"Goff","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"e1001444","DOI":"10.1371\/journal.pmed.1001444","article-title":"Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study.","volume":"10","author":"Spuesens","year":"2013","journal-title":"PLoS Med"},{"key":"R24-20260109","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jmii.2020.10.002","article-title":"Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children.","volume":"54","author":"Tsai","year":"2021","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:00:15Z","timestamp":1767960015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004995","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]}}}